Lion-Point-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
21
Total Value
15675769
Accession Number
0001013594-25-000673
Form Type
13F-HR
Manager Name
Lion-Point-Capital-Lp
Data Enrichment
100% identified
21 identified0 unidentified

Holdings

21 positions • $15.7M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
INSMED Inc
Shares:30.5K
Value:$2.3M
% of Portfolio:14.8% ($2.3M/$15.7M)
ARDELYX, INC.
Shares:335.4K
Value:$1.6M
% of Portfolio:10.5% ($1.6M/$15.7M)
Mineralys Therapeutics, Inc.
Shares:79.0K
Value:$1.3M
% of Portfolio:8.0% ($1.3M/$15.7M)
FENNEC PHARMACEUTICALS INC.
Shares:195.7K
Value:$1.2M
% of Portfolio:7.6% ($1.2M/$15.7M)
Kiniksa Pharmaceuticals International, plc
Shares:45.9K
Value:$1.0M
% of Portfolio:6.5% ($1.0M/$15.7M)
BridgeBio Pharma, Inc.
Shares:26.0K
Value:$898.8K
% of Portfolio:5.7% ($898.8K/$15.7M)
Benitec Biopharma Inc.
Shares:62.0K
Value:$806.6K
% of Portfolio:5.1% ($806.6K/$15.7M)
GERON CORP
Shares:500.0K
Value:$795.0K
% of Portfolio:5.1% ($795.0K/$15.7M)
AVADEL PHARMACEUTICALS PLC
Shares:98.7K
Value:$772.8K
% of Portfolio:4.9% ($772.8K/$15.7M)
Arcutis Biotherapeutics, Inc.
Shares:46.3K
Value:$724.1K
% of Portfolio:4.6% ($724.1K/$15.7M)
Syndax Pharmaceuticals Inc
Shares:55.0K
Value:$675.7K
% of Portfolio:4.3% ($675.7K/$15.7M)
Jasper Therapeutics, Inc.
Shares:146.5K
Value:$630.0K
% of Portfolio:4.0% ($630.0K/$15.7M)
Biohaven Ltd.
Shares:22.7K
Value:$545.7K
% of Portfolio:3.5% ($545.7K/$15.7M)
Disc Medicine, Inc.
Shares:10.6K
Value:$526.2K
% of Portfolio:3.4% ($526.2K/$15.7M)
Milestone Pharmaceuticals Inc.
Shares:548.8K
Value:$439.1K
% of Portfolio:2.8% ($439.1K/$15.7M)
REGENXBIO Inc.
Shares:57.8K
Value:$412.9K
% of Portfolio:2.6% ($412.9K/$15.7M)
bluebird bio, Inc.
Shares:78.9K
Value:$385.1K
% of Portfolio:2.5% ($385.1K/$15.7M)
Seres Therapeutics, Inc.
Shares:340.8K
Value:$238.5K
% of Portfolio:1.5% ($238.5K/$15.7M)
Mersana Therapeutics, Inc.
Shares:644.0K
Value:$221.7K
% of Portfolio:1.4% ($221.7K/$15.7M)
Humacyte, Inc.
Shares:83.5K
Value:$142.4K
% of Portfolio:0.9% ($142.4K/$15.7M)